2025-04-18 - Analysis Report
## Intuitive Surgical Inc. (ISRG) Stock Report

**0. Key Figures:**

* **Cumulative Return (ISRG):** 109.17%
* **Cumulative Return (VOO/S&P 500):** 76.18%
* **Return Difference:** 33.0%
* **Relative Divergence:** 37.3% (Indicates ISRG outperformed VOO by a degree within the historical range of their divergence)
* **Current Closing Price:** $482.74


**1. Company Overview and Performance Comparison:**

Intuitive Surgical Inc. is a leading developer and manufacturer of robotic surgery systems.  Over the period reviewed, ISRG significantly outperformed the S&P 500 (VOO), boasting a 33% higher cumulative return. While the relative divergence suggests this outperformance is within the historical range of their performance differential, it still represents strong relative performance.

**Alpha and Beta Analysis:**

The provided data shows varying alpha and beta values across different time periods.  While beta generally increased over time, indicating increasing market sensitivity, the alpha values fluctuated, showing periods of outperformance (positive alpha) and underperformance (negative alpha) relative to the market. Note that the provided CAGR and MDD (Maximum Drawdown) figures show strong historical performance with periods of substantial risk.

| Year       | CAGR | MDD  | Alpha | Beta | Cap(B) |
|------------|------|------|-------|------|-------|
| 2015-2017  | 68.0% | 56.5% | 35.0% | -0.0 | 43.6 |
| 2016-2018  | 77.0% | 63.4% | 56.0% | -0.1 | 57.2 |
| 2017-2019  | 81.0% | 63.4% | 47.0% | 0.4 | 70.6 |
| 2018-2020  | 47.0% | 63.4% | 17.0% | 0.4 | 97.7 |
| 2019-2021  | 91.0% | 63.0% | 31.0% | 0.4 | 128.7 |
| 2020-2022  | -3.0% | 69.9% | -12.0% | 0.5 | 95.1 |
| 2021-2023  | -5.0% | 72.9% | -26.0% | 1.1 | 120.9 |
| 2022-2024  | 26.0% | 72.9% | 5.0% | 1.1 | 187.0 |
| 2023-2025  | 30.0% | 72.9% | 15.0% | 0.7 | 172.9 |


**2. Recent Price Movement:**

* **Closing Price:** $482.74
* **5-Day Moving Average:** $487.22
* **20-Day Moving Average:** $492.22
* **60-Day Moving Average:** $537.09

The price is currently below all three moving averages, suggesting a potential downward trend.


**3. Technical Indicators and Expected Return:**

* **Market Risk Indicator (MRI):** 0.4223 (Medium Risk)
* **RSI:** 47.78 (Approaching oversold territory, but not definitively so)
* **PPO:** 0.39 (Positive, indicating bullish momentum, though relatively weak)
* **20-Day Relative Divergence Change:** -0.9 (Short-term bearish signal)
* **Expected Return (2+ years):** 47.1% (Significant outperformance relative to the S&P 500 is anticipated over the long term).

The recent price change of $0.29 is relatively small and doesn't indicate a significant event.  The combination of indicators points to a mixed signal â€“ potential for a short-term downturn, but long-term prospects remain positive.

**4. Recent Earnings Analysis:**

The earnings data shows generally increasing revenue and relatively stable EPS.  There's no immediately obvious trend, however a potential slight slowdown in EPS growth is visible in the most recent quarters compared to the prior ones. Further analysis is needed to determine the cause of this potential slowdown.

| Date       | EPS  | Revenue       |
|------------|------|---------------|
| 2024-10-18 | 1.59 | $2.04 B       |
| 2024-07-19 | 1.48 | $2.01 B       |
| 2024-04-19 | 1.54 | $1.89 B       |
| 2023-10-20 | 1.18 | $1.74 B       |
| 2024-10-18 | 1.18 | $1.74 B       |  *(Duplicate entry, likely an error)*


**5. Financial Information:**

The financial information demonstrates strong and consistent profitability, with high profit margins.  Revenue has been generally increasing.  ROE is relatively stable, but has shown some recent fluctuation.  Further investigation into the specific drivers behind these figures would provide a more comprehensive understanding.

**Revenue and Profitability:**

| Quarter | Revenue | Profit Margin |
|---------|----------|---------------|
| 2024-12-31 | $2.41B | 68.04% |
| 2024-09-30 | $2.04B | 67.41% |
| 2024-06-30 | $2.01B | 68.30% |
| 2024-03-31 | $1.89B | 65.87% |
| 2023-12-31 | $1.93B | 66.24% |

**Capital and Profitability:**

| Quarter | Equity | ROE |
|---------|---------|-----|
| 2024-12-31 | $16.43B | 4.17% |
| 2024-09-30 | $15.58B | 3.63% |
| 2024-06-30 | $14.71B | 3.58% |
| 2024-03-31 | $13.96B | 3.90% |
| 2023-12-31 | $13.31B | 4.56% |


**6. Overall Analysis:**

ISRG demonstrates a strong track record of outperformance relative to the S&P 500, with a high cumulative return.  However, recent price action suggests a potential short-term bearish trend. Financial statements show healthy profitability and growing revenue.  The long-term outlook remains positive, supported by a high expected return, but investors should carefully monitor short-term market trends and fundamental developments.  Further analysis of the duplicate data point in the recent earnings, along with a deeper dive into the drivers of ROE fluctuations and recent EPS growth, is recommended before making investment decisions.
